Contributions of pulmonary hypertension to HIV-related cardiac dysfunction

Indian Heart Journal

Volumn 65, Issue 5, 2013, Pages 644-649

  Isiguzo, Godsent C ^a   Okeahialam, Basil N ^a   Danbauchi, Solomon S ^a   Odili, Augustine N ^b   Iroezindu, Michael O ^c   Placid, Ugoagwu ^d  

^a Federal Teaching Hospital Abakaliki   (Nigeria)

^b UNIVERSITY OF ABUJA   (Nigeria)

^c UNIVERSITY OF NIGERIA   (Nigeria)

^d UNIVERSITY OF JOS   (Nigeria)

Author keywords

Cardiac dysfunction; HIV; Pulmonary hypertension

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DECELERATION TIME; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FRACTIONAL SHORTENING; HEART DISEASE; HEART EJECTION FRACTION; HOMOSEXUALITY; HOSPITAL PATIENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PHYSICAL EXAMINATION; PREVALENCE; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; UNIVERSITY HOSPITAL; AGE DISTRIBUTION; COMORBIDITY; DISEASE COURSE; ECHOGRAPHY; FOLLOW UP; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HIV INFECTIONS; HYPERTENSION, PULMONARY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX RATIO; SURVIVAL; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PREVALENCE; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84888640390     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ihj.2013.08.010     Document Type: Letter

References (28)

1. Opravil M, Pechère M, Speich R, et al. HIV-associated primary pulmonary hypertension: A case control study. Swiss HIV cohort study. Am J Resp Crit Care Med. 1997;155:990-995
2. Simonneau G, Rubin IJ, Langleben D, Seeger W, Domenighetti G. Clinical classification of pulmonary hypertension. J Am Coll of Cardio. 2004;43:55-125
3. Masuyama T, Kodama K, Kitabataka A, Sato H, Nanto S, Inoue M. Continuous wave Doppler echocardiographic detection of pulmonary regurgitation and its implication to noninvasive estimation of pulmonary artery pressure. Circulation. 1986;74:484-493
4. Kim KK, Factor SM. Membrano proliferative glomerulonephritis and plexogenic pulmonary arteropathy in a homosexual man with AIDS. Hum Pathol. 1987;18:1293-1296
5. Nicolls MR, Taraseviciene-Stewart L, Rai PR, Badesch DB, Voelkel NF. Autoimmunity and pulmonary hypertension: A perspective. Eur Respir J. Dec;26:1110-1118
6. Tuder RM, Voelkel NF. Pulmonary hypertension and inflammation. J Lab Clin Med. 1998;132:16-24
7. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J. 2003;22:358-363
8. Nyeimrst H. Prognostic factors for survival in HIV associated pulmonary hypertension. Am J Resp Ant Care Med. 2003;1671: 1433-1439
9. Pelliceli AM. Primary pulmonary hypertension in HIV positive patients: A systematic review. Angiology. 2001;52:31-34
10. Jacob AJ, Boon NA. The role of HIV in heart disease. In: Banatvala J, ed. Viruses and the Heart. Sevenoales: Edward Arnod; 1993:176-195
11. Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA. HIV-related pulmonary hypertension: Analytical review of 131 cases. Chest. 2000;118:1133-1141
12. Sahn DJ, DeMaria A, Kisslo J, Wegman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083
13. Berger M, Haimowitz A, Van Tosh A, Badoff RL, Goldberg E. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation, using continuous wave Doppler ultrasound. J Am Coll Cardiol. 1985;6:359-363
14. Byers DK, Nayak G, Ferguson M. Prevalence of pulmonary hypertension in asymptomatic HIV-infected patients receiving antiretroviral therapy. In: Proceedings of 48th International Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Washington DC. 2008. Abstract H-2312
15. O?Alonzo GE. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991;115:343-349
16. Petitpretz P, Brenot F, Azarian R, et al. Pulmonary hypertension in patients with human immunodeficiency virus infection: Comparison with primary pulmonary hypertension. Circulation. 1994;89:2722-2727
17. Nunes H, Humbert M, Sitbon O Morse JH, et al. Prognostic factors for survival in human immunodeficiency virus associated pulmonary arterial hypertension. Am J Res Crit Care Med. 2003;167:1433-1439
18. Mesa RA, Edell ES, Dunn WF, Edwards WD. Human immunodeficiency virus infection and pulmonary hypertension: Two new cases and a review of 86 reported cases. Mayo Clin Proc. 1998;73:37-45
19. Zuber JP, Calcy A, Evison JM, et al. Pulmonary arterial hypertension related to HIV infection: Improved hemodynamic associated with anti-retroviral therapy. Clin Infect Dis. 2004;38:1178-1185
20. Bruunsgaard H, Pedersen M, Pedersen BK. Aging and proinflammatory cytokines. Curr Opin Hematol. 2001;131: 131-136
21. DeVeale B, Brumnel T, Seroude I. Immunity and aging: The enemy within? Aging Cell. 2004;3:195-208
22. Kritchevsky SB, Cesari M, Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Resp. 2005;66:265-275
23. Strephensen CB, Kelly DS. Innate immunity system: Friend and foe [Editorial]. Am J Clin Nutr. 2006;83:187-188
24. Michelsen KS, Doherty TM, Shah PK, Arditi M. TLR signaling: An emerging bridge from innate immunity to atherogenesis. J Immunol. 2004;173:5901-5907
25. Herbert VY, Crenshaw BL, Romanoff RL, Ekshyyan VP, Dugas TR. Effects of HIV drug combinations on endithelin-1 and vascular cell proliferation. Cardiovasc Toxicol. 2004;4: 117-131
26. Jiang B, Herbert VY, Zavecz JH, Dugas TR. Anti-retrovirals induced direct endothelial dysfunction in vivo. J Acquir Immune Defic Syndr. 2007;42:391-395
27. Wang X, Chai H, Yao Q, Chen C. Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction. J Acquir Immune Defic Syndr. 2007;44:493-499
28. Acikel M, Kose N, Aribas A, et al. Left ventricular diastolic function and pulmonary hypertension in chronic obstructive lung disease. Clin Cardiol. 2010;33:E13eE18